Larry Nichols
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Larry Nichols has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Aditi A. Dave
Department of Biomedical Sciences, Mercer University School of Medicine, Macon, GA 31207, USA
1 shared publication - Anasalea J. V. Caroland
Department of Biomedical Sciences, Mercer University School of Medicine, Macon, GA 31207, USA
1 shared publication - Angela Nguyen1 shared publication
- Ashley Lall
Mercer University School of Medicine. Macon, GA, USA
1 shared publication - Ashley Reavis McNeal
Obstetrics and Gynecology, Mercer University School of Medicine, Macon, USA
1 shared publication - Christy C. Bridges
Department of Biomedical Sciences, Mercer University School of Medicine, Macon, GA, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Autopsy Case Reports
- Vol. 14, e2024520
Stealth cryptococcus in an immunocompetent patient
Autops Case Rep, vol.14, e2024520, 2024
- 1 January 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Autopsy Case Reports
- Vol. 14, e2024520
Open AccessStealth cryptococcus in an immunocompetent patient
Autops Case Rep, vol.14, e2024520, 2024
- Open Access
- 23 September 2022
- Published by Elsevier in Academic Pathology
- Vol. 9 (1) , 100055
Educational Case: Hemolysis elevated liver enzymes and low platelets (HELLP syndrome)
- 23 September 2022
- Published by Elsevier in Academic Pathology
- Vol. 9 (1) , 100055
Open AccessEducational Case: Hemolysis elevated liver enzymes and low platelets (HELLP syndrome)
- Open Access
- 21 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11105
Molecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease
Chronic kidney disease (CKD) is a progressive disease that affects millions of adults every year. Major risk factors include diabetes, hypertension, and obesity, which affect millions of adults worldwide. CKD is characterized by cellular injury followed by permanent loss of functional nephrons. As injured cells die and nephrons become sclerotic, remaining healthy nephrons attempt to compensate by undergoing various structural, molecular, and functional changes. While these changes are designed to maintain appropriate renal function, they may lead to additional cellular injury and progression of disease. As CKD progresses and filtration decreases, the ability to eliminate metabolic wastes and environmental toxicants declines. The inability to eliminate environmental toxicants such as arsenic, cadmium, and mercury may contribute to cellular injury and enhance the progression of CKD. The present review describes major molecular alterations that contribute to the pathogenesis of CKD and the effects of arsenic, cadmium, and mercury on the progression of CKD.
- 21 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11105
Open AccessMolecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease
Chronic kidney disease (CKD) is a progressive disease that affects millions of adults every year. Major risk factors include diabetes, hypertension, and obesity, which affect millions of adults worldwide. CKD is characterized by cellular injury followed by permanent loss of functional nephrons. As injured cells die and nephrons become sclerotic, remaining healthy nephrons attempt to compensate by undergoing various structural, molecular, and functional changes. While these changes are designed to maintain appropriate renal function, they may lead to additional cellular injury and progression of disease. As CKD progresses and filtration decreases, the ability to eliminate metabolic wastes and environmental toxicants declines. The inability to eliminate environmental toxicants such as arsenic, cadmium, and mercury may contribute to cellular injury and enhance the progression of CKD. The present review describes major molecular alterations that contribute to the pathogenesis of CKD and the effects of arsenic, cadmium, and mercury on the progression of CKD.
- Open Access
- 16 August 2022
- Published by Elsevier in Academic Pathology
- Vol. 9 (1) , 100041
Educational Case: Neuromyelitis optica
- 16 August 2022
- Published by Elsevier in Academic Pathology
- Vol. 9 (1) , 100041
Open AccessEducational Case: Neuromyelitis optica
- Open Access
- 6 August 2022
- Published by Elsevier in Academic Pathology
- Vol. 9 (1) , 100042
Educational Case: Coccidioidomycosis
- 6 August 2022
- Published by Elsevier in Academic Pathology
- Vol. 9 (1) , 100042
Open AccessEducational Case: Coccidioidomycosis
- Open Access
- 20 July 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (12) , 6442-6443
Comparison of clinical characteristics of a patient with Epstein–Barr virus‐associated seizure and patients with COVID‐19‐associated seizure
- 20 July 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (12) , 6442-6443
Open AccessComparison of clinical characteristics of a patient with Epstein–Barr virus‐associated seizure and patients with COVID‐19‐associated seizure
- 13 May 2021
- Published by Marshfield Clinic Research Institute in Clinical Medicine & Research
- Vol. 19 (3) , 110-115
Where in the Brain do Strokes Occur? A Pilot Study and Call for Data
Background: Every year, more than 795,000 people in the United States have a stroke, and each year about 140,000 Americans die from strokes. Although there is abundant information on the epidemiology, risk factors, pathophysiology, and many clinical features of strokes, there is a lack of specific numerical quantitation on the neuroanatomical distribution of strokes.
- 13 May 2021
- Published by Marshfield Clinic Research Institute in Clinical Medicine & Research
- Vol. 19 (3) , 110-115
Where in the Brain do Strokes Occur? A Pilot Study and Call for Data
Background: Every year, more than 795,000 people in the United States have a stroke, and each year about 140,000 Americans die from strokes. Although there is abundant information on the epidemiology, risk factors, pathophysiology, and many clinical features of strokes, there is a lack of specific numerical quantitation on the neuroanatomical distribution of strokes.
- Open Access
- 1 January 2021
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Autopsy Case Reports
- Vol. 11, e2021311
Amniotic fluid embolism: lessons for rapid recognition and intervention
Autops Case Rep, vol.11, e2021311, 2021
- 1 January 2021
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Autopsy Case Reports
- Vol. 11, e2021311
Open AccessAmniotic fluid embolism: lessons for rapid recognition and intervention
Autops Case Rep, vol.11, e2021311, 2021
- Open Access
- 1 January 2021
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Autopsy Case Reports
- Vol. 11, e2021314
Ascariasis, trichuriasis and fatal non-transfusion
Autops Case Rep, vol.11, e2021314, 2021
- 1 January 2021
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Autopsy Case Reports
- Vol. 11, e2021314
Open AccessAscariasis, trichuriasis and fatal non-transfusion
Autops Case Rep, vol.11, e2021314, 2021
- 1 January 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (1) , 139
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome
- 1 January 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (1) , 139
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome